AU2001288392A1 - Delivery system for heparin-binding growth factors - Google Patents

Delivery system for heparin-binding growth factors

Info

Publication number
AU2001288392A1
AU2001288392A1 AU2001288392A AU8839201A AU2001288392A1 AU 2001288392 A1 AU2001288392 A1 AU 2001288392A1 AU 2001288392 A AU2001288392 A AU 2001288392A AU 8839201 A AU8839201 A AU 8839201A AU 2001288392 A1 AU2001288392 A1 AU 2001288392A1
Authority
AU
Australia
Prior art keywords
heparin
delivery system
growth factors
binding growth
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288392A
Inventor
Daniel D. Carson
Mary C. Farach-Carson
Margaret French
Ronald Gomes
Rupert Timpl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Delaware
Original Assignee
University of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Delaware filed Critical University of Delaware
Publication of AU2001288392A1 publication Critical patent/AU2001288392A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2001288392A 2000-08-30 2001-08-27 Delivery system for heparin-binding growth factors Abandoned AU2001288392A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22893500P 2000-08-30 2000-08-30
US60/228,935 2000-08-30
PCT/US2001/026512 WO2002017955A1 (en) 2000-08-30 2001-08-27 Delivery system for heparin-binding growth factors

Publications (1)

Publication Number Publication Date
AU2001288392A1 true AU2001288392A1 (en) 2002-03-13

Family

ID=22859152

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288392A Abandoned AU2001288392A1 (en) 2000-08-30 2001-08-27 Delivery system for heparin-binding growth factors

Country Status (3)

Country Link
US (2) US7671018B2 (en)
AU (1) AU2001288392A1 (en)
WO (1) WO2002017955A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666852B2 (en) * 2002-04-22 2010-02-23 Agenta Biotechnologies, Inc. Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US20090162436A1 (en) * 2006-06-14 2009-06-25 Carson Daniel D Compositions and methods for repair of tissues
US9187517B2 (en) * 2006-11-13 2015-11-17 The Brigham And Women's Hospital, Inc. Methods of promoting cardiac repair using growth factors fused to heparin binding sequences
SI2280720T1 (en) 2008-03-27 2019-06-28 Purdue Research Foundation Collagen-binding synthetic peptidoglycans, preparation, and methods of use
US9597412B2 (en) 2011-03-16 2017-03-21 University Of Delaware Injectable delivery system for heparan-binding growth factors
RU2617844C2 (en) 2011-05-24 2017-04-28 СИМИК АйПи, ЭлЭлСи Hyaluronic acid binding synthetic peptidoglycans, preparation and application methods
JP6603650B2 (en) 2013-03-15 2019-11-06 パーデュー・リサーチ・ファウンデーション Extracellular matrix-bound synthetic peptidoglycan
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
AU2018298224A1 (en) 2017-07-07 2020-01-30 Symic Ip, Llc Synthetic bioconjugates
CA3165586A1 (en) * 2020-01-23 2021-07-29 Avirus, Inc. Methods and compositions for treating and preventing viral infection
US11518788B2 (en) 2020-07-10 2022-12-06 Avirus, Inc. Methods and compositions for treating and preventing viral infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5661127A (en) * 1995-05-01 1997-08-26 The Regents Of The University Of California Peptide compositions with growth factor-like activity
US5842477A (en) * 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
CA2263895C (en) * 1996-08-26 2012-06-26 University Of Washington Therapeutic and diagnostic applications of perlecan domain i splice variants
AUPO832597A0 (en) 1997-07-30 1997-08-21 Cardiac Crc Nominees Pty Limited Wound treatment compositions
US5876730A (en) 1997-08-07 1999-03-02 Childrens Hospital Research Foundation Heparin-binding growth factor (HBGF) polypeptides
EP0896825B1 (en) * 1997-08-14 2002-07-17 Sulzer Innotec Ag Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors

Also Published As

Publication number Publication date
US7671018B2 (en) 2010-03-02
US20100221302A1 (en) 2010-09-02
WO2002017955A1 (en) 2002-03-07
US7875591B2 (en) 2011-01-25
US20040063619A1 (en) 2004-04-01
WO2002017955A9 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
AU2001285161A1 (en) Delivery point validation system
AU2001288388A1 (en) Substance delivery system
AU2001273178A1 (en) Stent delivery system
AU2002325034A1 (en) Stent delivery system
AU2001268879A1 (en) Injection system for gene delivery
AU2001288392A1 (en) Delivery system for heparin-binding growth factors
AU2001275992A1 (en) Date specific package delivery system
AU2001260244A1 (en) Product delivery system
AU2002354927A1 (en) Vapor delivery system
AU2001270846A1 (en) System for feeding line
AU6254101A (en) Delivery receptable system
AU2002222138A1 (en) Drug delivery system
AUPR434401A0 (en) Fuel delivery system
AUPQ974300A0 (en) Fluid delivery system
AU2001213286A1 (en) Multi-valve delivery system
GB0014898D0 (en) Delivery system
AU2002210580A1 (en) Drug delivery system
AU2002223799A1 (en) Nutrient delivery system
AU2001238040A1 (en) Offer delivery system
AU4248800A (en) Intelligent delivery system for directed content
AUPQ616800A0 (en) Secure delivery system
AU2001248954A1 (en) Iscom polypeptide delivery system
AUPR132800A0 (en) Fuel delivery system
AU2002218904A1 (en) Pharmaceutical delivery system
AUPR146700A0 (en) Drug delivery system